We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Office of Pharmaceutical Quality Revs Up Process to Accelerate ANDA Reviews
FDA’s Office of Pharmaceutical Quality Revs Up Process to Accelerate ANDA Reviews
In a preview of how the FDA’s Office of Pharmaceutical Quality will speed approval of generic drugs, the office is rolling out a framework for ANDA filers to respond to minor agency queries involving chemistry, manufacturing and control issues early in the review cycle.